Travere Therapeutics · 1 week ago
Vice President, Clinical Development (Rare Metabolic Disease)
Travere Therapeutics is a biopharmaceutical company dedicated to delivering innovative therapies for rare diseases. The Vice President of Clinical Development will oversee clinical and strategic initiatives for rare metabolic disease programs, collaborating with cross-functional teams to ensure high-quality clinical development strategies and execution.
BiotechnologyHealth CareMedical
Responsibilities
Co-lead for assigned development programs as part of the Program Strategy Team (PST) and represents the program to executive leadership and study team members
Responsible for effectively communicating program goals, strategies, plans, issues and risks with team members, department heads, review boards, and the executive team
Deep understanding of working with cross-functional team members to create clinical development plans, timelines, risk tradeoffs including regular engagement/presentations with regulatory agencies is critical
Responsible for leading the development of protocols and clinical/scientific strategy for Phase 1-4
Understanding of the development and regulatory strategy (from pre-IND to NDA/BLA) and devices (Human Factor studies) to provide clinical and scientific insights as part of the PST
Understanding and knowledge of the rare metabolic and genetic disease areas as well as the future landscape and treatment paradigm in order to provide strategic input into future development needs, biometrics analyses, publications, and core presentations
Partners with Biometrics to plan data entry, analysis, and interpretation for the PST and Medical Affairs colleagues
Accountable for clinical portions of protocols, investigator brochures, medical reports, efficacy and safety summaries, scientific rationales, and benefit/risk ratios
Lead and mentor Clinical Development staff, consultants, and vendor medical monitor to foster a high-performance culture within the Clinical Development department
Proactively establishes and maintains relationships with stakeholders i.e., alliance partners, external companies, investigators, and key opinion leaders
Attend and present at investigator meetings and site initiation visits as applicable
Works cross-functionally with medical affairs and prepares manuscripts, posters, and other scientific communications and conducts presentations at scientific meetings
Understanding of governance and ability to represent the programs and key decisions at cross-functional governance meetings
Additional duties assigned as needed
Qualification
Required
M.D. or M.D./Ph.D. degree or equivalent required. Equivalent combination of education and applicable job experience may be considered
12+ years of experience in clinical research including the design and execution of clinical trials, preferably within a pharmaceutical or biotech environment although time spent in relevant high caliber academic clinical research will be counted towards the total; 8+ years leadership experience
Demonstrated ability to lead cross-functional teams in a matrix environment
Deep understanding of working with cross-functional team members to create clinical development plans, timelines, risk tradeoffs including regular engagement/presentations with regulatory agencies is critical
Understanding of the development and regulatory strategy (from pre-IND to NDA/BLA) and devices (Human Factor studies) to provide clinical and scientific insights as part of the PST
Understanding and knowledge of the rare metabolic and genetic disease areas as well as the future landscape and treatment paradigm in order to provide strategic input into future development needs, biometrics analyses, publications, and core presentations
Partners with Biometrics to plan data entry, analysis, and interpretation for the PST and Medical Affairs colleagues
Accountable for clinical portions of protocols, investigator brochures, medical reports, efficacy and safety summaries, scientific rationales, and benefit/risk ratios
Lead and mentor Clinical Development staff, consultants, and vendor medical monitor to foster a high-performance culture within the Clinical Development department
Proactively establishes and maintains relationships with stakeholders i.e., alliance partners, external companies, investigators, and key opinion leaders
Attend and present at investigator meetings and site initiation visits as applicable
Works cross-functionally with medical affairs and prepares manuscripts, posters, and other scientific communications and conducts presentations at scientific meetings
Understanding of governance and ability to represent the programs and key decisions at cross-functional governance meetings
Ability to travel domestically and internationally (up to 25 to 30%)
All positions have an essential job function to be able to perform face to face work with colleagues and/or onsite in San Diego. No role is expected to be 100% remote
Preferred
Metabolics/genetics and/or rare disease experience and NDA/BLA submissions is strongly preferred
Experiences with devices and human factors studies preferred
Benefits
Premium health
Financial
Work-life and well-being offerings for eligible employees and dependents
Wellness and employee support programs
Life insurance
Disability
Retirement plans with employer match
Generous paid time off
Company
Travere Therapeutics
Travere discovers and develops drugs for the treatment of catastrophic diseases that are debilitating and often life-threatening.
H1B Sponsorship
Travere Therapeutics has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (3)
2024 (3)
2023 (2)
2021 (1)
Funding
Current Stage
Public CompanyTotal Funding
$1.07BKey Investors
Athyrium Capital Management LP
2024-11-07Post Ipo Equity· $125M
2023-02-28Post Ipo Equity· $200M
2022-03-08Post Ipo Debt· $275M
Recent News
TradingView
2025-12-30
2025-12-25
Company data provided by crunchbase